Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
If your practice compounds or administers non-commercial formulations, now is the time for a legal compliance check-up.
Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes
Clinical Data on Body Composition Available clinical trial data on body composition changes with these compounds remains limited but suggests favorable profiles
Avoid self-medication
Last reviewed: May 22, 2026 Last updated: May 22, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
/i.s3.glbimg.com/v1/AUTH_da025474c0c44edd99332dddb09cabe8/internal_photos/bs/2024/e/i/NqJEYGQTuHx0mgSS8ntA/mounjaro.jpg)
/i.s3.glbimg.com/v1/AUTH_63b422c2caee4269b8b34177e8876b93/internal_photos/bs/2023/x/r/pMRvbgQMSD0K9vY4mQNA/mounjaro-pens-desktop.png)
US$ 21.35
US$ 22.76
US$ 25.32
